Screening neuroprotective compounds in herpes-induced Alzheimer's disease cell and 3D tissue models
- PMID: 35537596
- DOI: 10.1016/j.freeradbiomed.2022.05.002
Screening neuroprotective compounds in herpes-induced Alzheimer's disease cell and 3D tissue models
Abstract
Alzheimer's Disease (AD) is a neurodegenerative disorder that can cause life-altering and debilitating cognitive decline. AD's etiology is poorly understood, and no disease-modifying therapeutics exist. Here, we describe the use of 2D and 3D tissue culture models of herpesvirus-induced AD, which recapitulate hallmark disease features of plaque formation, gliosis, neuroinflammation, and impaired neuronal signaling, to screen a panel of 21 medications, supplements, and nutraceuticals with purported neuroprotective benefits. This screen identified green tea catechins and resveratrol as having strong anti-plaque properties, functional neuroprotective benefits, and minimal neurotoxicity, providing support for their further investigation as AD preventives and therapies. Two other candidates, citicoline and metformin, reduced plaque formation and were minimally toxic, but did not protect against virus-induced impairments in neuronal signaling. This study establishes a simple platform for rapidly screening and characterizing AD compounds of interest in 2D and 3D human cortical tissue models representing physiologically relevant disease features.
Keywords: 3D culture; Alzheimer's disease; Bioengineering; Screening.
Copyright © 2022 Elsevier Inc. All rights reserved.
Similar articles
-
A 3D human brain-like tissue model of herpes-induced Alzheimer's disease.Sci Adv. 2020 May 6;6(19):eaay8828. doi: 10.1126/sciadv.aay8828. eCollection 2020 May. Sci Adv. 2020. PMID: 32494701 Free PMC article.
-
Molecular Insight into the Therapeutic Promise of Flavonoids against Alzheimer's Disease.Molecules. 2020 Mar 11;25(6):1267. doi: 10.3390/molecules25061267. Molecules. 2020. PMID: 32168835 Free PMC article. Review.
-
Liraglutide and a lipidized analog of prolactin-releasing peptide show neuroprotective effects in a mouse model of β-amyloid pathology.Neuropharmacology. 2019 Jan;144:377-387. doi: 10.1016/j.neuropharm.2018.11.002. Epub 2018 Nov 11. Neuropharmacology. 2019. PMID: 30428311
-
Angelica tenuissima Nakai Ameliorates Cognitive Impairment and Promotes Neurogenesis in Mouse Model of Alzheimer's Disease.Chin J Integr Med. 2018 May;24(5):378-384. doi: 10.1007/s11655-017-2812-2. Epub 2017 Jun 3. Chin J Integr Med. 2018. PMID: 28578486
-
Caffeine for Prevention of Alzheimer's Disease: Is the A2A Adenosine Receptor Its Target?Biomolecules. 2023 Jun 8;13(6):967. doi: 10.3390/biom13060967. Biomolecules. 2023. PMID: 37371547 Free PMC article. Review.
Cited by
-
Anthocyanins: Molecular Aspects on Their Neuroprotective Activity.Biomolecules. 2023 Oct 31;13(11):1598. doi: 10.3390/biom13111598. Biomolecules. 2023. PMID: 38002280 Free PMC article. Review.
-
Comprehensive Review of Nutraceuticals against Cognitive Decline Associated with Alzheimer's Disease.ACS Omega. 2023 Sep 20;8(39):35499-35522. doi: 10.1021/acsomega.3c04855. eCollection 2023 Oct 3. ACS Omega. 2023. PMID: 37810693 Free PMC article. Review.
-
Functional bioengineered tissue models of neurodegenerative diseases.Biomaterials. 2023 Jul;298:122143. doi: 10.1016/j.biomaterials.2023.122143. Epub 2023 May 2. Biomaterials. 2023. PMID: 37146365 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
